Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $95.3500 (4.2%) ($93.3200 - $98.1600) on Thu. Aug. 1, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.58% (three month average) | RSI | 24 | Latest Price | $95.3500(4.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2.3% a day on average for past five trading days. | Weekly Trend | LGND declines -7.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.29% in a week (0% probabilities). VIXM(-33%) VXX(-21%) TLT(-15%) IFRA(-9%) UUP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.29% (StdDev 2.58%) | Hourly BBV | 0 () | Intraday Trend | 2.1% | | | |
|
Resistance Level | $110.21 | 5 Day Moving Average | $99.52(-4.19%) | 10 Day Moving Average | $104.63(-8.87%) | 20 Day Moving Average | $110.21(-13.48%) | To recent high | -25% | To recent low | 4.2% | Market Cap | $1.532b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |